FOXO4-DRI is a synthetic senolytic peptide designed to target and eliminate senescent cells by disrupting the interaction between FOXO4 and p53 proteins. This selective action triggers natural apoptosis in dysfunctional cells while protecting healthy ones, supporting cellular renewal and healthy aging processes.

• It uses a retro-inverso D-amino acid structure that enhances stability and resistance to breakdown in biological environments compared to standard peptides.
• The peptide specifically binds to the FOXO4-p53 complex found predominantly in senescent cells, freeing p53 to activate cell death pathways.
• Researchers value its high selectivity, which minimizes impact on non-senescent cells and reduces potential off-target effects.
• This mechanism addresses one root cause of aging by clearing accumulated “zombie” cells that secrete inflammatory signals.
• In research settings, it promotes tissue homeostasis and may improve overall resilience at the cellular level.
• Its design allows effective performance at lower concentrations while maintaining strong biological activity.

 Research on FOXO4-DRI highlights its potential to support healthy aging through senescent cell clearance, leading to reduced inflammation, better tissue function, and improved physical vitality in study models.

• Studies show it may enhance kidney and testicular tissue health by removing damaged cells that impair organ performance.
• It supports mitochondrial efficiency, which can translate to better energy production and cellular metabolism.
• Many protocols explore its role in reducing chronic low-grade inflammation linked to senescent cell secretions.
• Animal research indicates possible improvements in mobility, recovery speed, and overall physical resilience.
• It promotes vascular health and may aid natural repair processes in aged tissues.
• Long-term observations in models suggest benefits for maintaining youthful cellular environments and hormone balance.

 We supply FOXO4-DRI as a high-purity lyophilized powder in sterile glass vials, making it stable for storage and easy to reconstitute for research applications.

• Each vial typically contains 10 mg of the peptide, providing sufficient material for multiple research doses.
• The lyophilized form protects the peptide from degradation and extends shelf life when kept properly.
• Vials arrive sealed and sterile, ready for use with bacteriostatic water or appropriate research solvents.
• Our packaging ensures the product remains protected during discreet worldwide shipping.
• Clear labeling includes batch details and storage recommendations for consistent research quality.
• This format allows precise dosing and convenient handling in laboratory or research settings.

 FOXO4-DRI stands out due to its targeted peptide-based mechanism that focuses specifically on the FOXO4-p53 pathway, offering greater selectivity than many small-molecule senolytics.

• Unlike broad-acting compounds, it primarily affects senescent cells while largely sparing healthy proliferating cells.
• Its peptide structure provides unique binding precision not easily achieved with flavonoids or BCL-2 inhibitors.
• Research models demonstrate stronger effects in certain tissues such as kidneys and reproductive organs.
• The retro-inverso modification increases its durability and effectiveness duration in biological systems.
• It serves as a valuable tool for studying precise cellular clearance without widespread systemic disruption.
• Many researchers combine it strategically with other approaches for complementary senolytic effects.

 Researchers commonly explore FOXO4-DRI in combination with supportive peptides to enhance overall research outcomes related to aging and tissue renewal.

• Pairing it with regenerative peptides like BPC-157 or TB-500 may amplify tissue repair signals after senescent cell clearance.
• Growth hormone secretagogues such as CJC-1295 or Ipamorelin are sometimes studied alongside for synergistic vitality effects.
• Combining with anti-inflammatory peptides can help manage the temporary inflammatory response during cell clearance.
• Protocols vary based on specific research goals, with many using staggered or cyclic approaches.
• Always follow proper reconstitution and dosing guidelines when exploring combinations in controlled studies.
• We provide high-purity versions of complementary peptides to support flexible research designs.

FOXO4-DRI is primarily researched for its role in senolytic therapy, focusing on the selective removal of senescent cells to support healthy aging, tissue regeneration, and improved organ function in preclinical models.

• Studies heavily explore its effects on age-related decline in kidneys, where senescent cell buildup often leads to reduced filtration efficiency.
• Research examines its potential in reproductive tissues, particularly testes, to restore hormone balance and cellular vitality.
• Many protocols investigate its ability to reduce systemic inflammation caused by senescent cell secretions known as SASP.
• Scientists study its impact on vascular health and endothelial function in aging cardiovascular models.
• It serves as a key tool in longevity research aimed at extending healthspan through targeted cellular cleanup.
• Ongoing work evaluates its use in recovery from chemotherapy or stress-induced senescence in various tissues.

 FOXO4-DRI should be stored in a cool, dry place away from direct light to maintain maximum stability in its lyophilized form, with refrigeration required after reconstitution.

• Keep unopened vials at room temperature (below 25°C / 77°F) or in a refrigerator for longer shelf life.
• Avoid freezing the lyophilized powder as it is not necessary and may cause unnecessary moisture issues.
• Once reconstituted with bacteriostatic water, store the solution in the refrigerator at 2-8°C.
• Use within 2-4 weeks after mixing for best research potency and consistency.
• Always seal vials tightly and minimize exposure to air or humidity during handling.
• Proper storage helps preserve the peptide’s structural integrity for reliable experimental results.

 FOXO4-DRI is typically used in short to medium research cycles rather than indefinite long-term continuous administration, allowing observation of clearance effects followed by recovery periods.

• Most studies employ intermittent dosing schedules with breaks to evaluate sustained benefits after senescent cell removal.
• Researchers monitor tissue response over weeks to months rather than years of daily use.
• Cyclic protocols help prevent potential adaptation and allow natural cellular renewal processes to take effect.
• Long-term observations in animal models focus on repeated short courses spaced apart.
• This approach supports better understanding of healthspan improvements without constant intervention.
• We recommend following established research designs that include clear on/off periods for safety and efficacy tracking.

 The standard reconstitution method for FOXO4-DRI involves slowly adding bacteriostatic water to the lyophilized powder and gently swirling until fully dissolved for accurate research dosing.

• Use sterile syringes and bacteriostatic water to maintain sterility throughout the process.
• Add the solvent drop by drop along the vial wall to avoid foaming or damaging the peptide.
• Gently swirl or roll the vial between fingers—never shake vigorously.
• Allow the solution to clear completely before drawing doses for experiments.
• Reconstituted solution should appear clear and free of particles for quality assurance.
• Store the mixed vial immediately in the refrigerator and note the preparation date.

 Yes, FOXO4-DRI has demonstrated promising effects in animal models, particularly in aged mice, where it improves physical function, tissue health, and markers of aging after senescent cell clearance.

• Research in aged rodents shows enhanced kidney function and reduced markers of fibrosis.
• Studies report restored testosterone levels and improved testicular tissue quality in older male models.
• Treated animals often exhibit better grip strength, mobility, and overall physical performance.
• Reductions in chronic inflammation and senescent cell burden appear consistently across multiple studies.
• Vascular and heart tissue improvements have been noted in models of accelerated aging.
• These preclinical results position FOXO4-DRI as a valuable compound for further aging research.

 FOXO4-DRI supports cellular health by selectively clearing senescent “zombie” cells that accumulate with age, reducing their harmful inflammatory secretions and creating a better environment for healthy cell function and tissue renewal.

• It disrupts the FOXO4-p53 binding that keeps damaged cells alive, allowing natural apoptosis to occur.
• This clearance helps lower chronic inflammation known as inflammaging at the cellular level.
• Healthy cells remain largely unaffected, preserving normal tissue regeneration processes.
• Research shows potential improvements in mitochondrial function and energy production within cells.
• It promotes a more youthful cellular environment by reducing the burden of dysfunctional cells.
• Overall, it aids in maintaining tissue homeostasis and resilience against age-related decline.

 You can expect ≥98% purity for FOXO4-DRI from Peptide Union, with each batch verified through high-performance liquid chromatography (HPLC) testing for consistent research quality.

• Our rigorous quality control ensures minimal impurities and high peptide integrity.
• Every vial includes batch-specific testing documentation for transparency.
• We source and synthesize under strict standards to meet research-grade requirements.
• High purity supports accurate dosing and reliable experimental outcomes.
• Customers receive stable, high-quality product that performs consistently in studies.
• We maintain this standard across all our peptide offerings for full trustworthiness.

 Common research observations with FOXO4-DRI include improved physical performance, reduced inflammation markers, and enhanced tissue function in aged models following senescent cell clearance.

• Many studies note better mobility, grip strength, and recovery after treatment.
• Reductions in SASP-related inflammatory factors appear regularly in results.
• Organ-specific improvements, especially in kidneys and testes, are frequently reported.
• Researchers often observe restored hormone balance in older animal subjects.
• Enhanced vascular health and energy levels represent consistent positive findings.
• Effects tend to build over time as the body responds to lower senescent cell load.

 We process and ship FOXO4-DRI orders quickly, with most orders prepared for same-day or next-day dispatch after payment confirmation to support fast and reliable delivery.

• Payment verification usually completes within a few hours during business times.
• We use efficient packaging and trusted carriers for worldwide shipping.
• Customers receive a tracking number as soon as the order leaves our facility.
• Overnight and expedited options are available depending on location.
• Our streamlined process minimizes wait times while maintaining full discretion.
• We monitor every shipment to ensure timely and safe arrival.

 Our policies protect your FOXO4-DRI purchase with a 30-day full refund or replacement guarantee, discreet packaging, tracking, and reliable worldwide delivery for complete peace of mind.

• We stand behind product quality with straightforward refund or replacement options.
• Every package uses plain, unmarked materials for maximum privacy.
• A tracking number is provided with every order for full visibility.
• We focus on 100% customer satisfaction through responsive support.
• Secure payment methods and clear processes protect your transaction.
• Our commitment to reliability ensures a smooth and trusted buying experience.